Finding Reasons To Take Nibbles As COVID-19 Has Covered Every Part Of Our World

The key to placing a Buy order in a market that doesn't know where it's bottom truly will rest--35%-65% market correction we feel from seeing the many technicals pointing towards.

WHY IS INOVIO PHARMACEUTICALS CORP INO FIRST ON THE HITLIST OF SCREAMING BUYS?

(Click on image to enlarge)

When It Counts For Real - INO
Inovio Pharmaceuticals Copyright 2020 

Whats probably 80 million more times as important as COVID-19 are the 80 MILLION FOLKS actually INFECTED with the HPV VIRUS. The recent run-up in the share price of Inovio to $19.43 was just the begging; as we see the share price tracking like Regeneron stock chart as 12-24 months hitting between $98-$148 dollars a share. 

The key to placing a Buy order in a market that doesn't know where it's bottom truly will rest--35%-65% MARKET CORRECTION we feel from seeing the many technicals pointing towards. Start looking at the true supports for the likes of Amazon AMZN

iNOVIO is much closer then they have ever been with the U.S. FDA as they are also with the Chinese Authorities. It's the newest forged relationships due impart because of COVID-19 as they have the ear of President Donald J. Trump and the folks charged who keep with the FDA standards of excellence. Not to mention the success of INO-3107 just approved with an Orphan - Drug status placed on the fast track to gain FDA approval.

THE HUGE WHOPPER THAT'S BIGGER THAN COVID-19

That's right! The huge whopper of getting FDA approval is around the corner for Inovio's pipeline drug of VGX-3100. They have been hitting all the benchmarks with them having great success with HPV patients battling Cervical HSIL, Vulvar HSIL, and Anal HSIL. 

Keep Apple AAPL on your radar at between supports of $158 - $225 a share. AMZN on your radar at $1475.50 - $1698.00. WYNN all day long at share prices between $63 - $78 a share.

Remember to review my other articles on what makes safe entry and exit type trading. 

Disclosure:

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.  

STOCKS IN THIS ARTICLE

Also Mentions:

Comments